PA-PPG
8.8.2016 14:12:52 CEST | Business Wire | Press release
PPG (NYSE:PPG) today announced the completion of a COLORFUL COMMUNITIES™ project in Soborg, Denmark, that helped to revitalize and add shelter and seating to the parkour area of the City’s Arena, an outdoor activity space adjacent to the Hoje Gladsaxe housing project. The Colorful Communities program provides PPG employees and products along with financial contributions to bring color and vitality to communities where our company operates around the world. The program increases PPG’s commitment to invest in communities by adding $10 million to support efforts made during a 10-year period.
The project brought together more than 30 volunteers who are employees at PPG’s nearby architectural coatings, automotive refinish, and protective and marine coatings operations in Soborg to spend two days revitalizing the parkour area. PPG provided more than $18,500 for the project, as well as about 150 liters of DYRUP® Façade Extra paint products in 10 colors.
Young residents who use the City's Arena (Byens Arena) – an outdoor area that encourages movement, activity and play, mostly for residents of the adjacent 2,500-unit Hoje Gladsaxe housing project – expressed a desire for development and beautification of the parkour area. There was a need to make the area more welcoming in the hope of inviting more use. Large concrete features were installed to provide shelter and accommodation for visitors, and artist Anders Benmouyal facilitated a workshop where PPG employees and Hoje Gladsaxe residents came together and decorated the new concrete features.
“From the beginning, we were sure that revitalizing an area of Hoje Gladsaxe was right for this project – the residents are so close to our site, they are actually our neighbors,” said Peter Soerensen, PPG general manager, architectural coatings, Denmark. “We hope this is the beginning of close cooperation on more community initiatives. Already we are planning an educational day at our PPG site for local school students.”
The Colorful Communities program is PPG’s signature initiative for community engagement efforts, with the aim to protect and beautify the neighborhoods where PPG operates around the world. Together with community partners and PPG employees who volunteer, the program supports projects that transform community assets using donated PPG products. In 2015, PPG completed 11 Colorful Communities projects, and it expects to complete about 30 more this year.
PPG and the PPG Foundation aim to bring color and brightness to PPG communities around the world. We donated more than $7.8 million in 2015 to hundreds of community organizations across 20 countries. By investing in educational opportunities, we help grow today’s skilled workforce and develop tomorrow’s innovators in industries related to coatings and specialty materials. Plus, we empower PPG employees to make an impact for causes that are important to them by supporting their volunteer efforts and charitable giving. Learn more at www.ppgcommunities.com and follow @PPG_Communities on Twitter.
PPG: WE PROTECT AND BEAUTIFY THE WORLD™
At PPG (NYSE:PPG), we work every day to develop and deliver the paints, coatings and materials that our customers have trusted for more than 130 years. Through dedication and creativity, we solve our customers’ biggest challenges, collaborating closely to find the right path forward. With headquarters in Pittsburgh, we operate and innovate in more than 70 countries and reported net sales of $15.3 billion in 2015. We serve customers in construction, consumer products, industrial and transportation markets and aftermarkets. To learn more, visit www.ppg.com .
We protect and beautify the world and Colorful Communities are trademarks and the PPG Logo is a registered trademark of PPG Industries Ohio, Inc.
Dyrup is a registered trademark of Dyrup A/S.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160808005028/en/
Contact:
PPG Media:
Mark Silvey, +1 412-434-3046
Corporate
Communications
silvey@ppg.com
www.ppgcommunities.com
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release
If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids
Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release
Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use
DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release
-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating
HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 11:18:00 CEST | Press release
HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi
Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 10:28:00 CEST | Press release
Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
